Study of an Artificial Human Skin Medicine for Patients With Basal Cell Carcinoma Undergoing Reconstructive Surgery

PHASE2RecruitingINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 21, 2022

Primary Completion Date

January 1, 2024

Study Completion Date

December 1, 2024

Conditions
Basal Cell Carcinoma
Interventions
BIOLOGICAL

PHITAH

Tissue Engineered Human Artificial Skin: Fibrin-Hyaluronic Acid

BIOLOGICAL

PHIT

Human artificial skin created by tissue engineering: fibrin-agarose

BIOLOGICAL

Skin Autograft

Skin Autograft

Trial Locations (4)

4109

RECRUITING

Hospital U. Virgen Macarena, Seville

18014

RECRUITING

Hospital U. Virgen de las Nieves, Granada

29010

RECRUITING

Hospital U. Virgen de la Victoria, Málaga

29603

RECRUITING

Hospital Costa del Sol, Marbella

All Listed Sponsors
lead

Andalusian Network for Design and Translation of Advanced Therapies

OTHER